1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biosimilars Business Review Q3 2015

Biosimilars Business Review Q3 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 32 pages

Industry Trend Analysis - Changes To Biologic Naming Conventions Gain Air Of Inevitability
Industry Trend Analysis - Biosimilars Will Be Essential In Future RA Treatment Options
Industry Trend Analysis - FDA's Expectations Indicate A Rapidly-Emerging Biosimilar Market Ahead
Industry Trend Analysis - Remsima On Course To Be A Global Biosimilar
Industry Brief - Epirus and Polpharma Enter Biosimilar Collaboration
Industry Trend Analysis - US Biosimilar Market Tangible But Zarxio's Acceptance Will Be Challenging
Industry Brief - Oncobiologics Secures Biosimilar Development Financing
Industry Brief - Fujifilm Kyowa Kirin Biologics And AstraZeneca Form JV To Develop Anti-VEGF Biosimilar
Industry Brief - Sorrento Enters Biosimilars Licensing Agreement With Mabtech
Industry Trend Analysis - Glatopa And Biosimilars Will Be Increasingly Important For Sandoz
Industry Trend Analysis - NICE Infliximab Pack Shows Way Forward For Introducing Biosimilars
Industry Brief - Hetero Launches Biosimilar Rituximab In India
Industry Brief - STADA And Gedeon Richter Enter Pegfilgrastim Agreement
Industry Trend Analysis - Pfizer/Hospira Growth Prospects Undiminished Despite EC Biosimilar Ruling
Industry Trend Analysis - Without Education, Biosimilar Uptake Will Be Hampered By Doubts
Industry Brief - PrOmnitrope Secures Canadian Approval For New Indications
Industry Brief - Biosimilar Etanercept Approved In South Korea
Industry Brief - Sandoz Inaugurates BioInject
Industry Trend Analysis - Amgen And Allergan's Biosimilar Bevacizumab On Target For Blockbuster Status

Table Of Contents

Biosimilars Business Review Q3 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

Global Biosimilar Drug Market Research Report 2016

Global Biosimilar Drug Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Biosimilar Drug Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilar Drug industry, focusing on the main regions ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.